0001181431-12-040546.txt : 20120712 0001181431-12-040546.hdr.sgml : 20120712 20120712163235 ACCESSION NUMBER: 0001181431-12-040546 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120710 FILED AS OF DATE: 20120712 DATE AS OF CHANGE: 20120712 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FRIEDMAN PAUL A CENTRAL INDEX KEY: 0001236927 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12400 FILM NUMBER: 12959593 MAIL ADDRESS: STREET 1: C/O INCYTE CORPORATION STREET 2: 3160 PORTER DRIVE CITY: PALO LATO STATE: CA ZIP: 94304 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INCYTE CORP CENTRAL INDEX KEY: 0000879169 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 943136539 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ROUTE 141 & HENRY CLAY ROAD STREET 2: BUILDING E336 CITY: WILMINGTON STATE: DE ZIP: 19880 BUSINESS PHONE: 3024986700 MAIL ADDRESS: STREET 1: ROUTE 141 & HENRY CLAY ROAD STREET 2: BUILDING E336 CITY: WILMINGTON STATE: DE ZIP: 19880 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE CORP DATE OF NAME CHANGE: 20030318 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE GENOMICS INC DATE OF NAME CHANGE: 20000710 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930902 4 1 rrd350691.xml X0306 4 2012-07-10 0 0000879169 INCYTE CORP INCY 0001236927 FRIEDMAN PAUL A EXPERIMENTAL STATION ROUTE 141 & HENRY CLAY ROAD WILMINGTON DE 19880 1 1 0 0 Chief Executive Officer Common Stock 2012-07-10 4 M 0 5556 3.11 A 315263 D Common Stock 2012-07-10 4 M 0 6480 8.99 A 321743 D Common Stock 2012-07-10 4 M 0 834 8.99 A 322577 D Common Stock 2012-07-10 4 M 0 10441 8.64 A 333018 D Common Stock 2012-07-10 4 M 0 1875 8.64 A 334893 D Incentive Stock Option (right to buy) 3.11 2012-07-10 4 M 0 5556 0 D 2016-01-26 Common Stock 5556 0 D Incentive Stock Option (right to buy) 8.99 2012-07-10 4 M 0 6480 0 D 2015-01-17 Common Stock 6480 0 D Incentive Stock Option (right to buy) 8.99 2012-07-10 4 M 0 834 0 D 2015-01-17 Common Stock 834 0 D Incentive Stock Option (right to buy) 8.64 2012-07-10 4 M 0 10441 0 D 2014-02-26 Common Stock 10441 0 D Incentive Stock Option (right to buy) 8.64 2012-07-10 4 M 0 1875 0 D 2014-02-26 Common Stock 1875 0 D Beginning January 27, 2009, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years. Beginning January 18, 2005, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Beginning February 27, 2004, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. /s/ Paul A. Friedman 2012-07-12